EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

In vitro resistance to daptomycin of staphylococcus aureus and enterococcus spp. strains

Irina Stan, Mihaela Botnarciuc, Liliana Tuţă, Emma Gheorghe

ARS Medica Tomitana · 2014

DOI: 10.1515/arsm-2015-0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ARS Medica Tomitana, 2014. Verfasst von Irina Stan und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Daptomycin is the first antibiotic in a new class of cyclic lipopeptides, active in vitro against Gram - positive cocci. The mechanism of action is a rapid depolarization of the bacterial membrane potential, loss of cytoplasmic contents, mainly K+ ions and inhibition of protein, DNA and RNA synthesis, followed by the bacterial cell death. There were investigated 112 strains of Gram-positive cocci recommended for daptomycin susceptibility testing. Since the main clinical indications of daptomycin are the severe skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus, vancomicin-resistant enterococci and penicillinresistant Streptococcus spp, we tested daptomycin activity only in these species. The susceptibility tests was performed by Kirby- Bauer disc-diffusion method on Muller-Hinton agar supplemented with Ca 50 mg / ml. (CAMH - Ca 2 + ) as recommended by CLSI. During the period in which we conducted the study we isolated 112 strains of Gram-positive cocci, which we tested sensitivity to daptomycin. Resistance to Daptomycin of Staphylococcus aureus (4.11%) was lower than resistance to vancomycin (6.76%), but higher than the resistance to teicoplanin (2.71%) and linezolid (1.38%). In our study we did not identify daptomycin resistant strains of Enterococcus spp. In severe infections that require more aggressive treatment using active antibiotics on MRSA, daptomycin is a valid therapeutic option, but a susceptibility test is required to ensure effective indication. There were no daptomycin resistant Enterococcus spp. strains

Zitieren

APA

Stan, I., Botnarciuc, M., Tuţă, L., & Gheorghe, E. (2014). In vitro resistance to daptomycin of staphylococcus aureus and enterococcus spp. strains. ARS Medica Tomitana. https://doi.org/10.1515/arsm-2015-0005

Vancouver

Stan I, Botnarciuc M, Tuţă L, Gheorghe E. In vitro resistance to daptomycin of staphylococcus aureus and enterococcus spp. strains. ARS Medica Tomitana. 2014. doi:10.1515/arsm-2015-0005

BibTeX
@article{Stan2014,
  author = {Stan, Irina and Botnarciuc, Mihaela and Tuţă, Liliana and Gheorghe, Emma},
  title = {In vitro resistance to daptomycin of staphylococcus aureus and enterococcus spp. strains},
  journal = {ARS Medica Tomitana},
  year = {2014},
  doi = {10.1515/arsm-2015-0005}
}
Kostenlos starten →